Current Protein Identity：B6DRA0
New Search
Difference tags compare only the current result set; every original PDB and assembly record remains separate.
Related-Structure Differences
Each row represents one biological assembly in one PDB entry; multiple monomers of the same protein are listed separately.
| PDB Entry | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Experimental Method | Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 5MCX The structure of the mature HIV-1 CA hexamer in intact virus particles Deposited 2016-11-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric（24） Consistent with protein count |
Chain A
133–353（221 aa）
Chain B
133–353（221 aa）
Chain C
133–353（221 aa）
Chain D
133–353（221 aa）
Chain E
133–353（221 aa）
Chain F
133–353（221 aa）
Chain G
133–353（221 aa）
Chain I
133–353（221 aa）
Chain J
133–353（221 aa）
Chain K
133–353（221 aa）
Chain L
133–353（221 aa）
Chain N
133–353（221 aa）
Chain O
133–353（221 aa）
Chain P
133–353（221 aa）
Chain Q
133–353（221 aa）
Chain R
133–353（221 aa）
Chain S
133–353（221 aa）
Chain U
133–353（221 aa）
Chain V
133–353（221 aa）
Chain W
133–353（221 aa）
Chain Y
133–353（221 aa）
Chain Z
133–353（221 aa）
Chain b
133–353（221 aa）
Chain c
133–353（221 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE；10nm colloidal gold was added to the sample prior to plunge freezing
|
Resolution 6.80 Å |
| 5MCY The structure of the mature HIV-1 CA pentamer in intact virus particles Deposited 2016-11-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 20 PDB declaration: eicosameric（20） Consistent with protein count |
Chain A
133–353（221 aa）
Chain B
133–353（221 aa）
Chain F
133–353（221 aa）
Chain G
133–353（221 aa）
Chain M
133–353（221 aa）
Chain N
133–353（221 aa）
Chain O
133–353（221 aa）
Chain P
133–353（221 aa）
Chain Q
133–353（221 aa）
Chain R
133–353（221 aa）
Chain S
133–353（221 aa）
Chain T
133–353（221 aa）
Chain Z
133–353（221 aa）
Chain b
133–353（221 aa）
Chain c
133–353（221 aa）
Chain d
133–353（221 aa）
Chain e
133–353（221 aa）
Chain f
133–353（221 aa）
Chain g
133–353（221 aa）
Chain h
133–353（221 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE；10nm colloidal gold was added to the sample prior to plunge freezing
|
Resolution 8.80 Å |
| 5UP4 Structure of the HIV-1 Capsid Protein and spacer peptide 1 by Cryo-EM Deposited 2017-02-01 | Assembly 1 Protein homooligomer Homooligomer；Protein × 18 PDB declaration: octadecameric（18） Consistent with protein count |
Chain B
133–353（221 aa）
Chain C
133–353（221 aa）
Chain D
133–353（221 aa）
Chain E
133–353（221 aa）
Chain F
133–353（221 aa）
Chain G
133–353（221 aa）
Chain H
133–353（221 aa）
Chain I
133–353（221 aa）
Chain J
133–353（221 aa）
Chain K
133–353（221 aa）
Chain L
133–353（221 aa）
Chain M
133–353（221 aa）
Chain N
133–353（221 aa）
Chain O
133–353（221 aa）
Chain P
133–353（221 aa）
Chain Q
133–353（221 aa）
Chain R
133–353（221 aa）
Chain S
133–353（221 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 9.00 Å |
| 5W4O Structure of the R18A mutant of the HIV-1 capsid protein Deposited 2017-06-12 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：residues 133-363
|
Mutation：R18A | IOD IODIDE ION × 54 CL CHLORIDE ION × 42 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.09 Å R-free 0.246 |
| 5W4P Structure of the E28A mutant of the HIV-1 capsid protein Deposited 2017-06-12 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：residues 133-363
|
Mutation：E28A | IOD IODIDE ION × 72 CL CHLORIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.19 Å R-free 0.246 |
| 5W4Q Structure of the R18A/E28A mutant of the HIV-1 capsid protein Deposited 2017-06-12 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：residues 133-363
|
Mutation：R18A, E28A | IOD IODIDE ION × 42 CL CHLORIDE ION × 42 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.29 Å R-free 0.245 |
| 6AXR Structure of the P122A mutant of the HIV-1 capsid protein Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：P122A | IOD IODIDE ION × 48 CL CHLORIDE ION × 30 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.30 Å R-free 0.268 |
| 6AXS Structure of the V11I/T58A/P122A mutant of the HIV-1 capsid protein Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：V11I, T58A, P122A | IOD IODIDE ION × 60 CL CHLORIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.40 Å R-free 0.266 |
| 6AXT Structure of the T58S/T107I/P122A mutant of the HIV-1 capsid protein Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：T58S, T107I, P122A | IOD IODIDE ION × 54 CL CHLORIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, MIB, Glycerol
|
Resolution 2.40 Å R-free 0.243 |
| 6AXV Structure of the T58S/T107I/P122A mutant of the HIV-1 capsid protein in complex with PF-3450074 (PF74) Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：T58S, T107I, P122A | IOD IODIDE ION × 30 CL CHLORIDE ION × 54 1B0 N-METHYL-NALPHA-[(2-METHYL-1H-INDOL-3-YL)ACETYL]-N-PHENYL-L-PHENYLALANINAMIDE × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacosylate, Glycerol
|
Resolution 2.77 Å R-free 0.279 |
| 6AXW Structure of the I124A mutant of the HIV-1 capsid protein Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–362（230 aa）
Fragment：UNP residues 133-362
|
Mutation：I124A | IOD IODIDE ION × 54 CL CHLORIDE ION × 60 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, MIB, Glycerol
|
Resolution 2.40 Å R-free 0.236 |
| 6AXX Structure of the T58A/I124A mutant of the HIV-1 capsid protein Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：T58A, I124A | IOD IODIDE ION × 48 CL CHLORIDE ION × 54 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, MIB, Glycerol
|
Resolution 2.60 Å R-free 0.246 |
| 6AXY Structure of the V11I/T58A/I124A mutant of the HIV-1 capsid protein Deposited 2017-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：V11I, T58A, I124A | IOD IODIDE ION × 42 CL CHLORIDE ION × 54 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.78 Å R-free 0.260 |
| 6AY9 Structure of the native full-length HIV-1 capsid protein in complex with CPSF6 peptide Deposited 2017-09-07 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Not recorded | IOD IODIDE ION × 36 CL CHLORIDE ION × 24 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.50 Å R-free 0.273 |
| 6B2G P38A mutant of HIV-1 capsid protein Deposited 2017-09-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：P38A | IOD IODIDE ION × 48 CL CHLORIDE ION × 30 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, MIB, Glycerol
|
Resolution 2.41 Å R-free 0.258 |
| 6B2H P38A/T216I mutant of the HIV-1 capsid protein Deposited 2017-09-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：P38A, T216I | IOD IODIDE ION × 36 CL CHLORIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.60 Å R-free 0.241 |
| 6B2I E45A mutant of the HIV-1 capsid protein Deposited 2017-09-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：E45A | IOD IODIDE ION × 18 CL CHLORIDE ION × 72 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.50 Å R-free 0.250 |
| 6B2J E45A mutant of HIV-1 capsid protein (other crystal form) Deposited 2017-09-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：E45A | IOD IODIDE ION × 60 CL CHLORIDE ION × 24 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, MIB, Glycerol
|
Resolution 2.21 Å R-free 0.223 |
| 6B2K E45A/R132T mutant of HIV-1 capsid protein Deposited 2017-09-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：E45A, R132T | IOD IODIDE ION × 48 CL CHLORIDE ION × 42 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG3350, NaI, Sodium cacodylate, Glycerol
|
Resolution 2.00 Å R-free 0.218 |
| 6ERM HIV Hexamer with ligand Deposited 2017-10-18 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–351（219 aa）
|
Not recorded | AZT 3'-AZIDO-3'-DEOXYTHYMIDINE-5'-TRIPHOSPHATE × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
BATCH MODE；277 K；PEG4K
|
Resolution 2.00 Å R-free 0.235 |
| 6ERN HIV Hexamer with ligand Deposited 2017-10-18 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
139–351（213 aa）
|
Not recorded | ATP ADENOSINE-5'-TRIPHOSPHATE × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
BATCH MODE；277 K；PEG4K
|
Resolution 2.36 Å R-free 0.237 |
| 6MQA Structure of HIV-1 CA P207S Deposited 2018-10-09 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：P207S | IOD IODIDE ION × 18 CL CHLORIDE ION × 12 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION；293 K；15% PEG3350, 0.1 M sodium iodide, 0.1 M Bis-Tris propane
|
Resolution 3.20 Å R-free 0.219 |
| 6MQO Structure of HIV-1 CA G208R Deposited 2018-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：G208R | IOD IODIDE ION × 12 | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；pH 6.5；293 K；15% PEG3350, 0.1 M sodium iodide, Bis-Tris propane, pH 6.5
|
Resolution 3.20 Å R-free 0.271 |
| 6MQP Structure of HIV-1 CA T210K Deposited 2018-10-10 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：T210K | IOD IODIDE ION × 12 CL CHLORIDE ION × 12 | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；pH 5.8；293 K；15% PEG3350, 0.1 M sodium iodide, 0.1 M sodium cacodylate
|
Resolution 3.30 Å R-free 0.240 |
| 6OBH Structure of HIV-1 CA 1/2-hexamer Deposited 2019-03-20 | Assembly 1 Protein heterocomplex Heteromer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain B
133–363（231 aa）
Fragment：UNP residues 133-363
Chain E
133–363（231 aa）
Fragment：UNP residues 133-363
|
Mutation：E45C, T54C, W184A, M185A Mutation：E45C, T54C, W184A, M185A | NA SODIUM ION × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；pH 8；293 K；0.1 M PCB buffer, pH 8 (sodium propionate, sodium cacodylate, Bis-Tris propane), 25% w/v PEG1500
|
Resolution 2.96 Å R-free 0.265 |
| 6OMT HIV-1 capsid hexamer R18D mutant Deposited 2019-04-19 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A, R18D | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；293.15 K；0.1 M Tris-HCl, pH 8.5, 8% PEG8000
|
Resolution 2.05 Å R-free 0.221 |
| 6PU1 Cysteine stabilized hexameric HIV-1 CA in complex with SEC24C peptide Deposited 2019-07-16 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A | IOD IODIDE ION × 18 CL CHLORIDE ION × 18 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277.15 K；12% PEG3350, 24% glycerol, 0.35 M NaI, 50 mM sodium cacodylate pH 6.5
|
Resolution 2.28 Å R-free 0.272 |
| 6R6Q HIV capsid hexamer with IP5 ligand Deposited 2019-03-27 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–351（219 aa）
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
BATCH MODE；293 K；PEG 6K, 0.1M NaCl
|
Resolution 2.73 Å R-free 0.289 |
| 6R8C HIV capsid hexamer with IP5 ligand Deposited 2019-04-01 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–351（219 aa）
|
Not recorded | 5MY MYO-INOSITOL-(1,3,4,5,6)-PENTAKISPHOSPHATE × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
BATCH MODE；270 K；PEG 6K, 1M NaCl
|
Resolution 1.92 Å R-free 0.234 |
| 6V2F Crystal structure of the HIV capsid hexamer bound to the small molecule long-acting inhibitor, GS-6207 Deposited 2019-11-22 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
|
Not recorded | QNG Lenacapavir × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.7；298 K；12% PEG 3350, 0.2 M sodium thiocyanate, 0.1 M sodium cacodylate, pH 6.7
|
Resolution 2.00 Å R-free 0.251 |
| 6V2F Crystal structure of the HIV capsid hexamer bound to the small molecule long-acting inhibitor, GS-6207 Deposited 2019-11-22 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
|
Not recorded | QNG Lenacapavir × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.7；298 K；12% PEG 3350, 0.2 M sodium thiocyanate, 0.1 M sodium cacodylate, pH 6.7
|
Resolution 2.00 Å R-free 0.251 |
| 6V2F Crystal structure of the HIV capsid hexamer bound to the small molecule long-acting inhibitor, GS-6207 Deposited 2019-11-22 | Assembly 3 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Not recorded | QNG Lenacapavir × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.7；298 K；12% PEG 3350, 0.2 M sodium thiocyanate, 0.1 M sodium cacodylate, pH 6.7
|
Resolution 2.00 Å R-free 0.251 |
| 6VKV Co-crystal structure of GS-6207 bound to HIV-1 capsid hexamer Deposited 2020-01-22 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A | QNG Lenacapavir × 6 IOD IODIDE ION × 12 CL CHLORIDE ION × 24 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277.15 K；0.125-0.35M Sodium Iodide, 3-12% Peg 3350, 6% glycerol, 0.1M sodium cacodylate pH 6.5
|
Resolution 2.22 Å R-free 0.269 |
| 6VKV Co-crystal structure of GS-6207 bound to HIV-1 capsid hexamer Deposited 2020-01-22 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A | QNG Lenacapavir × 6 IOD IODIDE ION × 6 CL CHLORIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277.15 K；0.125-0.35M Sodium Iodide, 3-12% Peg 3350, 6% glycerol, 0.1M sodium cacodylate pH 6.5
|
Resolution 2.22 Å R-free 0.269 |
| 6VWS Hexamer of Helical HIV capsid by RASTR method Deposited 2020-02-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–352（220 aa）
Chain B
133–352（220 aa）
Chain C
133–352（220 aa）
Chain D
133–352（220 aa）
Chain M
133–352（220 aa）
Chain N
133–352（220 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 8；1M NaCl, 50mM Tris pH 8.0
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.08 Å |
| 7MKC N74D mutant of the HIV-1 capsid protein in complex with PF-3450074 (PF74) Deposited 2021-04-23 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：N74D | 1B0 N-METHYL-NALPHA-[(2-METHYL-1H-INDOL-3-YL)ACETYL]-N-PHENYL-L-PHENYLALANINAMIDE × 6 IOD IODIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG 3350, NaI, Sodium Cacodylate, Glycerol
|
Resolution 2.65 Å R-free 0.242 |
| 7MN0 N74D mutant of the HIV-1 capsid protein Deposited 2021-04-30 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：N74D | IOD IODIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；PEG 3350, NaI, Sodium Cacodylate, Glycerol
|
Resolution 2.90 Å R-free 0.274 |
| 7N9U CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions Deposited 2021-06-18 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–354（222 aa）
Fragment：UNP residues 133-354
Chain B
133–354（222 aa）
Fragment：UNP residues 133-354
Chain C
133–354（222 aa）
Fragment：UNP residues 133-354
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；295 K；0.1 M Bis-Tris propane:HCl, pH 7.0, 1.4 M sodium malonate, pH 7.0
|
Resolution 3.19 Å R-free 0.258 |
| 7N9V CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions Deposited 2021-06-18 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–354（222 aa）
Fragment：UNP residues 133-354
Chain C
133–354（222 aa）
Fragment：UNP residues 133-354
Chain D
133–354（222 aa）
Fragment：UNP residues 133-354
Chain G
133–354（222 aa）
Fragment：UNP residues 133-354
Chain I
133–354（222 aa）
Fragment：UNP residues 133-354
Chain K
133–354（222 aa）
Fragment：UNP residues 133-354
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；297 K；potassium nitrate, pH 6.9, 20% PEG3350
|
Resolution 3.45 Å R-free 0.258 |
| 7N9X CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions Deposited 2021-06-18 | Assembly 1 Protein heterocomplex Heteromer；Protein × 18 PDB declaration: octadecameric（18） Consistent with protein count |
Chain AAA
133–354（222 aa）
Fragment：UNP residues 133-354
Chain BBB
133–354（222 aa）
Fragment：UNP residues 133-354
Chain CCC
133–354（222 aa）
Fragment：UNP residues 133-354
|
Not recorded | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
MICROBATCH；295 K；100 mM Bis-Tris propane, pH 6.8, 15% PEG3350, 200 mM sodium
|
Resolution 3.51 Å R-free 0.270 |
| 7OVQ Immature HIV-1 matrix structure Deposited 2021-06-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric（24） Consistent with protein count |
Chain A
2–116（115 aa）
Chain B
2–116（115 aa）
Chain C
2–116（115 aa）
Chain D
2–116（115 aa）
Chain E
2–116（115 aa）
Chain F
2–116（115 aa）
Chain I
2–116（115 aa）
Chain K
2–116（115 aa）
Chain M
2–116（115 aa）
Chain O
2–116（115 aa）
Chain P
2–116（115 aa）
Chain Q
2–116（115 aa）
Chain R
2–116（115 aa）
Chain S
2–116（115 aa）
Chain X
2–116（115 aa）
Chain Y
2–116（115 aa）
Chain Z
2–116（115 aa）
Chain b
2–116（115 aa）
Chain c
2–116（115 aa）
Chain d
2–116（115 aa）
Chain f
2–116（115 aa）
Chain h
2–116（115 aa）
Chain l
2–116（115 aa）
Chain m
2–116（115 aa）
|
Not recorded | MYR MYRISTIC ACID × 24 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 7.20 Å |
| 7OVR Mature HIV-1 matrix structure Deposited 2021-06-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 24 PDB declaration: 24-meric（24） Consistent with protein count |
Chain A
2–116（115 aa）
Chain B
2–116（115 aa）
Chain C
2–116（115 aa）
Chain D
2–116（115 aa）
Chain E
2–116（115 aa）
Chain F
2–116（115 aa）
Chain H
2–116（115 aa）
Chain I
2–116（115 aa）
Chain J
2–116（115 aa）
Chain O
2–116（115 aa）
Chain P
2–116（115 aa）
Chain Q
2–116（115 aa）
Chain R
2–116（115 aa）
Chain S
2–116（115 aa）
Chain U
2–116（115 aa）
Chain W
2–116（115 aa）
Chain Y
2–116（115 aa）
Chain b
2–116（115 aa）
Chain c
2–116（115 aa）
Chain d
2–116（115 aa）
Chain e
2–116（115 aa）
Chain f
2–116（115 aa）
Chain j
2–116（115 aa）
Chain l
2–116（115 aa）
|
Not recorded | MYR MYRISTIC ACID × 24 PIO [(2R)-2-octanoyloxy-3-[oxidanyl-[(1R,2R,3S,4R,5R,6S)-2,3,6-tris(oxidanyl)-4,5-diphosphonooxy-cyclohexyl]oxy-phosphoryl]oxy-propyl] octanoate × 24 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 7.00 Å |
| 7RHM Structure of Q67H/N74D mutant of disulfide stabilized HIV-1 CA hexamer Deposited 2021-07-17 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Mutation：A14C, E45C, Q67H, N74D, W184A, M185A, | IOD IODIDE ION × 24 CL CHLORIDE ION × 30 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.35M NaI, 3% peg 3350, 6% glycerol, 0.1M sodium cacodylate trihydrate pH 6.5
|
Resolution 2.16 Å R-free 0.260 |
| 7RJ2 Co-crystal structure of lenacapavir bound to Q67H/N74D mutant of disulfide stabilized HIV-1 CA hexamer Deposited 2021-07-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Mutation：A14C, E45C, Q67H, N74D, W184A, M185A | QNG Lenacapavir × 6 CL CHLORIDE ION × 24 IOD IODIDE ION × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.425M NaI, 6% peg 3350, 6% glycerol, 0.1M sodium cacodylate trihydrate pH 6.5
|
Resolution 2.32 Å R-free 0.246 |
| 7RJ4 Co-crystal structure of lenacapavir bound to N74D mutant of disulfide stabilized HIV-1 CA hexamer Deposited 2021-07-20 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
|
Mutation：A14C, E45C, N74D, W184A, M185A Mutation：A14C, E45C, N74D, W184A, M185A | QNG Lenacapavir × 6 CL CHLORIDE ION × 36 IOD IODIDE ION × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.05M NaI, 3% peg 3350, 6% glycerol, 0.1M sodium cacodylate trihydrate pH 6.5
|
Resolution 3.32 Å R-free 0.331 |
| 7RJ4 Co-crystal structure of lenacapavir bound to N74D mutant of disulfide stabilized HIV-1 CA hexamer Deposited 2021-07-20 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Mutation：A14C, E45C, N74D, W184A, M185A | QNG Lenacapavir × 6 CL CHLORIDE ION × 36 IOD IODIDE ION × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.05M NaI, 3% peg 3350, 6% glycerol, 0.1M sodium cacodylate trihydrate pH 6.5
|
Resolution 3.32 Å R-free 0.331 |
| 7RMJ Disulfide stabilized HIV-1 CA hexamer in complex with capsid inhibitor (S)-N-(1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-(3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetamide Deposited 2021-07-27 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A | 61F N-[(1S)-1-(3-{4-chloro-3-[(methanesulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-(methanesulfonyl)-3-methylbut-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetamide × 6 IOD IODIDE ION × 9 CL CHLORIDE ION × 30 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.125M NaI, 4.5% Peg 3350, 6% glycerol, 0.1M sodium cacodylate pH 6.5
|
Resolution 2.27 Å R-free 0.248 |
| 7RMJ Disulfide stabilized HIV-1 CA hexamer in complex with capsid inhibitor (S)-N-(1-(3-(4-chloro-3-(methylsulfonamido)-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl)-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)-2-(3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)acetamide Deposited 2021-07-27 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A | 61F N-[(1S)-1-(3-{4-chloro-3-[(methanesulfonyl)amino]-1-(2,2,2-trifluoroethyl)-1H-indazol-7-yl}-6-[3-(methanesulfonyl)-3-methylbut-1-yn-1-yl]pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetamide × 6 IOD IODIDE ION × 12 CL CHLORIDE ION × 42 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.125M NaI, 4.5% Peg 3350, 6% glycerol, 0.1M sodium cacodylate pH 6.5
|
Resolution 2.27 Å R-free 0.248 |
| 7RMM Structure of N74D mutant of disulfide stabilized HIV-1 CA hexamer Deposited 2021-07-27 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
|
Mutation：A14C, E45C, N74D, W184A, M185A Mutation：A14C, E45C, N74D, W184A, M185A | IOD IODIDE ION × 12 CL CHLORIDE ION × 36 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.2M NaI, 5% peg 3350, 6% glycerol, 0.1M sodium cacodylate trihydrate pH 6.5
|
Resolution 1.97 Å R-free 0.246 |
| 7RMM Structure of N74D mutant of disulfide stabilized HIV-1 CA hexamer Deposited 2021-07-27 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Mutation：A14C, E45C, N74D, W184A, M185A | IOD IODIDE ION × 12 CL CHLORIDE ION × 30 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；277.15 K；0.2M NaI, 5% peg 3350, 6% glycerol, 0.1M sodium cacodylate trihydrate pH 6.5
|
Resolution 1.97 Å R-free 0.246 |
| 7T13 Hexameric HIV-1 (M-group) CA Q50Y mutant Deposited 2021-12-01 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Mutation：A14C, E45C, Q50Y, W184A, M185A Mutation：A14C, E45C, Q50Y, W184A, M185A Mutation：A14C, E45C, Q50Y, W184A, M185A Mutation：A14C, E45C, Q50Y, W184A, M185A Mutation：A14C, E45C, Q50Y, W184A, M185A Mutation：A14C, E45C, Q50Y, W184A, M185A | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 8；290 K；Crystallant: 19% (v/v) PEG 550MME, 100 mM TRIS (pH 8.0), 150 mM KSCN, 10 mM ATP, 3% (v/v) 3,5-hexanediol. Crystals grew in 2 ul protein (13 mg/ml) + 2 ul crystallant. Cryoprotected in 20% (v/v) MPD
|
Resolution 3.15 Å R-free 0.239 |
| 7URT T=1 particle HIV-1 CA G60A/G61P/M66A Deposited 2022-04-22 | Assembly 1 Protein homooligomer Homooligomer；Protein × 60 PDB declaration: 60-meric（60） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A/G61P/M66a | IHP INOSITOL HEXAKISPHOSPHATE × 120 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.39 Å |
| 7URT T=1 particle HIV-1 CA G60A/G61P/M66A Deposited 2022-04-22 | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A/G61P/M66a | IHP INOSITOL HEXAKISPHOSPHATE × 2 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.39 Å |
| 7URT T=1 particle HIV-1 CA G60A/G61P/M66A Deposited 2022-04-22 | Assembly 3 Protein homooligomer Homooligomer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A/G61P/M66a | IHP INOSITOL HEXAKISPHOSPHATE × 10 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.39 Å |
| 7URT T=1 particle HIV-1 CA G60A/G61P/M66A Deposited 2022-04-22 | Assembly 4 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A/G61P/M66a | IHP INOSITOL HEXAKISPHOSPHATE × 12 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.39 Å |
| 7URT T=1 particle HIV-1 CA G60A/G61P/M66A Deposited 2022-04-22 | Assembly 5 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A/G61P/M66a | IHP INOSITOL HEXAKISPHOSPHATE × 2 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.39 Å |
| 8CKV HIV-1 mature capsid hexamer from CA-IP6 CLPs Deposited 2023-02-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.89 Å |
| 8CKW HIV-1 mature capsid pentamer from CA-IP6 CLPs Deposited 2023-02-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric（15） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.12 Å |
| 8CKX HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPs Deposited 2023-02-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.97 Å |
| 8CKY HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Nup153 peptide Deposited 2023-02-16 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.60 Å |
| 8CKZ HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to Nup153 peptide Deposited 2023-02-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric（15） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.07 Å |
| 8CL0 HIV-1 mature capsid hexamer next to pentamer (type I) from CA-IP6 CLPs bound to Nup153 peptide. Deposited 2023-02-16 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.12 Å |
| 8CL1 HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to CPSF6 peptide. Deposited 2023-02-16 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.35 Å |
| 8CL2 HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to CPSF6 peptide Deposited 2023-02-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric（15） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.45 Å |
| 8CL3 HIV-1 mature capsid hexamer from CA-IP6 CLPs, bound to Sec24C peptide. Deposited 2023-02-16 | Assembly 1 Protein heterocomplex Heteromer；Protein × 12 PDB declaration: dodecameric（12） Consistent with protein count |
Chain A
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.14 Å |
| 8CL4 HIV-1 mature capsid pentamer from CA-IP6 CLPs bound to Sec24C peptide Deposited 2023-02-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 15 PDB declaration: pentadecameric（15） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.1
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.14 Å |
| 8D3B Hexameric HIV-1 (M-group) Q50Y/R120 mutant Deposited 2022-06-01 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Mutation：Q50Y, R120(insertion), A14C, E45C, W185A, M186A Mutation：Q50Y, R120(insertion), A14C, E45C, W185A, M186A Mutation：Q50Y, R120(insertion), A14C, E45C, W185A, M186A Mutation：Q50Y, R120(insertion), A14C, E45C, W185A, M186A Mutation：Q50Y, R120(insertion), A14C, E45C, W185A, M186A Mutation：Q50Y, R120(insertion), A14C, E45C, W185A, M186A | No recorded non-water small molecule | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8；290 K；20% PEG550MME, 0.1M TRIS (pH 8.0), 0.15M KSCN, 10mM ATP, 3% EtOH
|
Resolution 3.30 Å R-free 0.275 |
| 8EEP T=1 particle HIV-1 CA G60A/G61P Deposited 2022-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 60 PDB declaration: 60-meric（60） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A, G61P | IHP INOSITOL HEXAKISPHOSPHATE × 120 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.20 Å |
| 8EEP T=1 particle HIV-1 CA G60A/G61P Deposited 2022-09-07 | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A, G61P | IHP INOSITOL HEXAKISPHOSPHATE × 2 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.20 Å |
| 8EEP T=1 particle HIV-1 CA G60A/G61P Deposited 2022-09-07 | Assembly 3 Protein homooligomer Homooligomer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A, G61P | IHP INOSITOL HEXAKISPHOSPHATE × 10 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.20 Å |
| 8EEP T=1 particle HIV-1 CA G60A/G61P Deposited 2022-09-07 | Assembly 4 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A, G61P | IHP INOSITOL HEXAKISPHOSPHATE × 12 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.20 Å |
| 8EEP T=1 particle HIV-1 CA G60A/G61P Deposited 2022-09-07 | Assembly 5 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：G60A, G61P | IHP INOSITOL HEXAKISPHOSPHATE × 2 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 2.20 Å |
| 8EET T=1 particle HIV-1 CA M66A Deposited 2022-09-07 | Assembly 1 Protein homooligomer Homooligomer；Protein × 60 PDB declaration: 60-meric（60） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：M66A | IHP INOSITOL HEXAKISPHOSPHATE × 120 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 3.10 Å |
| 8EET T=1 particle HIV-1 CA M66A Deposited 2022-09-07 | Assembly 2 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：M66A | IHP INOSITOL HEXAKISPHOSPHATE × 2 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 3.10 Å |
| 8EET T=1 particle HIV-1 CA M66A Deposited 2022-09-07 | Assembly 3 Protein homooligomer Homooligomer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：M66A | IHP INOSITOL HEXAKISPHOSPHATE × 10 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 3.10 Å |
| 8EET T=1 particle HIV-1 CA M66A Deposited 2022-09-07 | Assembly 4 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：M66A | IHP INOSITOL HEXAKISPHOSPHATE × 12 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 3.10 Å |
| 8EET T=1 particle HIV-1 CA M66A Deposited 2022-09-07 | Assembly 5 Protein monomer Monomer；Protein × 1 PDB declaration: monomeric（1） Consistent with protein count |
Chain A
133–363（231 aa）
|
Mutation：M66A | IHP INOSITOL HEXAKISPHOSPHATE × 2 | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6
cryo-EM vitrification conditions
Cryogen ETHANE；Manual plunge-freezing
|
Resolution 3.10 Å |
| 8FIU Potent long-acting inhibitors targeting HIV-1 capsid based on a versatile quinazolin-4-one scaffold Deposited 2022-12-16 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
|
Not recorded | EDO 1,2-ETHANEDIOL × 15 Y05 N-[(1S)-1-{(3P)-3-{4-chloro-3-[(methanesulfonyl)amino]-1-methyl-1H-indazol-7-yl}-7-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-oxo-3,4-dihydroquinazolin-2-yl}-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-3-(difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 9；294 K；100 mM bicine, pH 9.0 and 14% (w/v) PEG3350
|
Resolution 1.56 Å R-free 0.194 |
| 8FIU Potent long-acting inhibitors targeting HIV-1 capsid based on a versatile quinazolin-4-one scaffold Deposited 2022-12-16 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain C
133–363（231 aa）
|
Not recorded | EDO 1,2-ETHANEDIOL × 12 Y05 N-[(1S)-1-{(3P)-3-{4-chloro-3-[(methanesulfonyl)amino]-1-methyl-1H-indazol-7-yl}-7-[(2R,6S)-2,6-dimethylmorpholin-4-yl]-4-oxo-3,4-dihydroquinazolin-2-yl}-2-(3,5-difluorophenyl)ethyl]-2-[(3bS,4aR)-3-(difluoromethyl)-5,5-difluoro-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 9；294 K；100 mM bicine, pH 9.0 and 14% (w/v) PEG3350
|
Resolution 1.56 Å R-free 0.194 |
| 8G6K HIV-1 CA lattice bound to IP6; from capsid-like particles Deposited 2023-02-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 35 PDB declaration: 35-meric（35） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 8G6K HIV-1 CA lattice bound to IP6; from capsid-like particles Deposited 2023-02-15 | Assembly 2 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 8G6K HIV-1 CA lattice bound to IP6; from capsid-like particles Deposited 2023-02-15 | Assembly 3 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å |
| 8G6L HIV-1 capsid lattice bound to IP6, pH 6.2 Deposited 2023-02-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 35 PDB declaration: 35-meric（35） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å |
| 8G6L HIV-1 capsid lattice bound to IP6, pH 6.2 Deposited 2023-02-15 | Assembly 2 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å |
| 8G6L HIV-1 capsid lattice bound to IP6, pH 6.2 Deposited 2023-02-15 | Assembly 3 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 6.2
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å |
| 8G6M HIV-1 CA lattice bound to IP6, pH 7.4 Deposited 2023-02-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 35 PDB declaration: 35-meric（35） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8G6M HIV-1 CA lattice bound to IP6, pH 7.4 Deposited 2023-02-15 | Assembly 2 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8G6M HIV-1 CA lattice bound to IP6, pH 7.4 Deposited 2023-02-15 | Assembly 3 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8G6N HIV-1 capsid lattice bound to dNTPs Deposited 2023-02-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 35 PDB declaration: 35-meric（35） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 8G6N HIV-1 capsid lattice bound to dNTPs Deposited 2023-02-15 | Assembly 2 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 8G6N HIV-1 capsid lattice bound to dNTPs Deposited 2023-02-15 | Assembly 3 Protein homooligomer Homooligomer；Protein × 7 PDB declaration: heptameric（7） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
Chain G
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å |
| 8G6O HIV-1 capsid lattice bound to IP6 and Lenacapavir Deposited 2023-02-15 | Assembly 1 Protein homooligomer Homooligomer；Protein × 25 PDB declaration: 25-meric（25） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8G6O HIV-1 capsid lattice bound to IP6 and Lenacapavir Deposited 2023-02-15 | Assembly 2 Protein homooligomer Homooligomer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8G6O HIV-1 capsid lattice bound to IP6 and Lenacapavir Deposited 2023-02-15 | Assembly 3 Protein homooligomer Homooligomer；Protein × 5 PDB declaration: pentameric（5） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
|
Not recorded | No recorded non-water small molecule | ELECTRON MICROSCOPY |
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å |
| 8TQP HIV-CA Disulfide linked Hexamer bound to Quinazolin-4-one Scaffold inhibitor Deposited 2023-08-08 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A | K3L 2-[4-(4-aminobenzene-1-sulfonyl)-2-oxopiperazin-1-yl]-N-{(1R)-2-(3,5-difluorophenyl)-1-[3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；291 K；PACT E4
|
Resolution 2.90 Å R-free 0.247 |
| 8TQP HIV-CA Disulfide linked Hexamer bound to Quinazolin-4-one Scaffold inhibitor Deposited 2023-08-08 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain G
133–363（231 aa）
Chain H
133–363（231 aa）
Chain I
133–363（231 aa）
Chain J
133–363（231 aa）
Chain K
133–363（231 aa）
Chain L
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A Mutation：A14C, E45C, W184A, M184A | K3L 2-[4-(4-aminobenzene-1-sulfonyl)-2-oxopiperazin-1-yl]-N-{(1R)-2-(3,5-difluorophenyl)-1-[3-(4-methoxyphenyl)-4-oxo-3,4-dihydroquinazolin-2-yl]ethyl}acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；291 K；PACT E4
|
Resolution 2.90 Å R-free 0.247 |
| 9PGS HIV Capsid Hexamer bound to Compound 6 Deposited 2025-07-08 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A | A1CH4 3,5-difluoro-Nalpha-[(5-hydroxy-1H-indol-3-yl)acetyl]-N-(4-methoxyphenyl)-N-methyl-L-phenylalaninamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277.15 K；30% PEG 8000, 0.1M sodium malonate
|
Resolution 2.40 Å R-free 0.261 |
| 9PGS HIV Capsid Hexamer bound to Compound 6 Deposited 2025-07-08 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain G
133–363（231 aa）
Chain H
133–363（231 aa）
Chain I
133–363（231 aa）
Chain J
133–363（231 aa）
Chain K
133–363（231 aa）
Chain L
133–363（231 aa）
|
Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A Mutation：A14C, E45C, W184A, M185A | A1CH4 3,5-difluoro-Nalpha-[(5-hydroxy-1H-indol-3-yl)acetyl]-N-(4-methoxyphenyl)-N-methyl-L-phenylalaninamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277.15 K；30% PEG 8000, 0.1M sodium malonate
|
Resolution 2.40 Å R-free 0.261 |
| 9PGT HIV Capsid Hexamer bound to Compound 12 Deposited 2025-07-08 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Not recorded | A1CH5 N-[(1S)-1-[3-(4-chlorophenyl)pyridin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293.15 K；12% PEG 8K, 0.1M sodium malonate
|
Resolution 2.20 Å R-free 0.247 |
| 9PGT HIV Capsid Hexamer bound to Compound 12 Deposited 2025-07-08 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain G
133–363（231 aa）
Chain H
133–363（231 aa）
Chain I
133–363（231 aa）
Chain J
133–363（231 aa）
Chain K
133–363（231 aa）
Chain L
133–363（231 aa）
|
Not recorded | A1CH5 N-[(1S)-1-[3-(4-chlorophenyl)pyridin-2-yl]-2-(3,5-difluorophenyl)ethyl]-2-(5-hydroxy-1H-indol-3-yl)acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293.15 K；12% PEG 8K, 0.1M sodium malonate
|
Resolution 2.20 Å R-free 0.247 |
| 9PGU HIV Capsid Hexamer bound to Compound 40 Deposited 2025-07-08 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Not recorded | A1CH6 (5M)-5-{2-[(1S)-2-(3,5-difluorophenyl)-1-{2-[(3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl]acetamido}ethyl]pyridin-3-yl}-2-fluorobenzamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293.15 K；7% peg 8000, 0.1M sodium malonate, pH 6.5
|
Resolution 3.36 Å R-free 0.262 |
| 9PGV HIV Capsid Hexamer bound to Compound 24 Deposited 2025-07-08 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
Chain B
133–363（231 aa）
Chain C
133–363（231 aa）
Chain D
133–363（231 aa）
Chain E
133–363（231 aa）
Chain F
133–363（231 aa）
|
Not recorded | A1CH7 N-methyl-N-phenyl-3-(pyridin-3-yl)-N~2~-{[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetyl}-L-alaninamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293.15 K；12% PEG 8000, 100 mM sodium malonate
|
Resolution 2.30 Å R-free 0.263 |
| 9PGV HIV Capsid Hexamer bound to Compound 24 Deposited 2025-07-08 | Assembly 2 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain G
133–363（231 aa）
Chain H
133–363（231 aa）
Chain I
133–363（231 aa）
Chain J
133–363（231 aa）
Chain K
133–363（231 aa）
Chain L
133–363（231 aa）
|
Not recorded | A1CH7 N-methyl-N-phenyl-3-(pyridin-3-yl)-N~2~-{[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]acetyl}-L-alaninamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293.15 K；12% PEG 8000, 100 mM sodium malonate
|
Resolution 2.30 Å R-free 0.263 |
| 9S6W HIV-1 capsid (M-group) - native in complex with JW3-100 Deposited 2025-08-01 | Assembly 1 Protein homooligomer Homooligomer；Protein × 6 PDB declaration: hexameric（6） Consistent with protein count |
Chain A
133–363（231 aa）
|
Not recorded | IOD IODIDE ION × 12 CL CHLORIDE ION × 24 BME BETA-MERCAPTOETHANOL × 6 1PG 2-(2-{2-[2-(2-METHOXY-ETHOXY)-ETHOXY]-ETHOXY}-ETHOXY)-ETHANOL × 6 A1JL5 (S)-N-(1-(5-((2-amino-2-oxoethyl)thio)-4-(4-(tert-Butyl)phenyl)-4H-1,2,4-triazol-3-yl)-2-(3,5-difluorophenyl)ethyl)-2-(5-hydroxy-1H-indol-3-yl)acetamide × 6 | X-RAY DIFFRACTION |
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；298 K；9.5-11% PEG 3350 (v/v), 250-350 mM NaI, 100 mM Sodium Cacodylate [pH 6.5].
Crystals grew in 1 uL protein (3 mg/mL) + 1 uL crystallant. Cryoprotected in 20% (v/v) Glycerol.
|
Resolution 2.07 Å R-free 0.298 |